{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T19:22:20Z","timestamp":1771269740640,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bone marker variability has raised concern for its use in individual patients. Serum osteocalcin (formation) and CTX (resorption) were measured every year for 4 years in 268 postmenopausal women. Seventy percent to 80% of women classified as having high bone turnover at baseline were similarly classified by the same methods 4 years later.<\/jats:p><jats:p>Introduction: High bone marker levels are a risk factor for osteoporosis in postmenopausal women, but variability of measurements has raised doubts about their clinical use in an individual patient.<\/jats:p><jats:p>Methods: We studied 268 untreated postmenopausal women (50\u201381 years of age) belonging to a population-based prospective cohort. We collected fasting morning blood samples every year for 4 years to measure serum intact osteocalcin (OC) and serum C-terminal cross-linked telopeptide of type I collagen (CTX) as bone formation and resorption markers, respectively.<\/jats:p><jats:p>Results: Serum OC and CTX remained stable during follow-up (+1.2%\/year, p = 0.003 and \u22120.13%\/year, p = 0.70 for OC and S-CTX, respectively). At baseline, women were classified as having low (tertile 1), intermediate (tertile 2), or high (tertile 3) bone turnover. Agreement of classification between baseline and 4-year measurements was moderate (\u03ba [95% CI]: 0.51 [0.43\u20130.59] and 0.52 [0.44\u20130.60] for OC and S-CTX, respectively). Less than 10% of women in tertile 1 or 3 of either marker at baseline were found in the opposite tertile 4 years later. When the two markers were combined, only 2% of women at high turnover at baseline\u2014defined as OC and\/or S-CTX in tertile 3\u2014were classified at low turnover 4 years later. Among women classified at high bone turnover at baseline (tertile 3), 70\u201380 % were also found at high turnover 4 years later. Among women in tertile 2, only 51% and 43% for OC and CTX, respectively, remained in the same tertile at the second measurement.<\/jats:p><jats:p>Conclusions: Serum levels of bone formation and resorption markers are stable over 4 years in postmenopausal women, on average. The majority of women classified as having high bone turnover were similarly classified by the same methods 4 years later. However, 20\u201330 % of these women at risk for fracture would be incorrectly classified, suggesting that further investigation would be required to reduce the number of patients who would be treated unnecessarily if the decision was made on bone marker measurement. For women with intermediate levels, classification may be improved by a second measurement or by combining two markers.<\/jats:p>","DOI":"10.1359\/jbmr.2003.18.10.1789","type":"journal-article","created":{"date-parts":[[2006,4,26]],"date-time":"2006-04-26T21:41:02Z","timestamp":1146087662000},"page":"1789-1794","source":"Crossref","is-referenced-by-count":57,"title":["Long-Term Variability of Markers of Bone Turnover in Postmenopausal Women and Implications for Their Clinical Use: The OFELY Study"],"prefix":"10.1093","volume":"18","author":[{"given":"Patrick","family":"Garnero","sequence":"first","affiliation":[{"name":"Synarc, Lyon, France"},{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Mulleman","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francoise","family":"Munoz","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Sornay-Rendu","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre D","family":"Delmas","sequence":"additional","affiliation":[{"name":"INSERM Research Unit 403, H\u00f4pital E Herriot, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024013019114533800_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"key":"2024013019114533800_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650081010","article-title":"Long-term fracture prediction by bone mineral density assessed at different skeletal sites","volume":"8","author":"Melton","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"key":"2024013019114533800_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s001980070064","article-title":"Long term risk of osteoporotic fractures in Malm\u00f6","volume":"11","author":"Kanis","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019114533800_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/bmj.312.7029.482","article-title":"Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study","volume":"312","author":"van Daele","year":"1996","journal-title":"BMJ"},{"key":"2024013019114533800_bib6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: The Epidos prospective study","volume":"11","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1359\/jbmr.2000.15.8.1526","article-title":"Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study","volume":"15","author":"Garnero","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s001980050009","article-title":"Serum Bone alkaline phosphatase and calcaneus bone density predict fractures: A prospective study","volume":"11","author":"Ross","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019114533800_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S8756-3282(00)00325-2","article-title":"Afternoon sampled serum type I collagen breakdown product (serum CTX) predicts hip fracture in elderly women: Results of the Epidos study","volume":"27","author":"Chapurlat","year":"2000","journal-title":"Bone"},{"issue":"Suppl 6","key":"2024013019114533800_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","article-title":"Markers of bone turnover for the prediction of fracture risk","volume":"11","author":"Garnero","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019114533800_bib11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s001980200068","article-title":"Biochemical indices of bone turnover and the assessment of fracture probability","volume":"13","author":"Johnell","year":"2002","journal-title":"Osteoporos Int"},{"issue":"Suppl 6","key":"2024013019114533800_bib12","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"issue":"Suppl 6","key":"2024013019114533800_bib13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1007\/s001980070004","article-title":"Preanalytical variability of biochemical markers of bone turnover","volume":"11","author":"Hannon","year":"2000","journal-title":"Osteoporos Int"},{"key":"2024013019114533800_bib14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","article-title":"Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: The Ofely Study","volume":"14","author":"Garnero","year":"1999","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jbmr.5650090215","article-title":"Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro","volume":"9","author":"Garnero","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"2024013019114533800_bib17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1359\/jbmr.2000.15.7.1398","article-title":"Biochemical markers as predictors of rates of bone loss after the menopause","volume":"15","author":"Rogers","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib18","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI110882","article-title":"Increase in serum bone \u03b3-carboxyglutamic acid protein with aging in women","volume":"71","author":"Delmas","year":"1983","journal-title":"J Clin Invest"},{"key":"2024013019114533800_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/jbmr.5650110307","article-title":"Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis","volume":"3","author":"Garnero","year":"1996","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jcem-69-6-1160","article-title":"Age and menopause-related changes in indices of bone turnover","volume":"69","author":"Kelly","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013019114533800_bib21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/jbmr.5650081102","article-title":"Importance of bone resorption in the determination of bone density in women more than 10 years past the menopause","volume":"8","author":"Prince","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024013019114533800_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(87)90002-0","article-title":"Bone loss and biochemical indices of bone remodeling in surgically postmenopausal women","volume":"8","author":"Stepan","year":"1987","journal-title":"Bone"},{"key":"2024013019114533800_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/bmj.303.6808.961","article-title":"Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study","volume":"303","author":"Hansen","year":"1991","journal-title":"BMJ"},{"key":"2024013019114533800_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00298429","article-title":"Evolution of spinal bone loss and biochemical markers of bone turnover after menopause in normal women","volume":"57","author":"Reeve","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"2024013019114533800_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/clinchem\/46.3.431a","article-title":"Circadian variation in serum Crosslaps concentration is reduced in fasting individuals","volume":"46","author":"Christgau","year":"2000","journal-title":"Clin Chem"},{"key":"2024013019114533800_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S8756-3282(02)00791-3","article-title":"Circadian variation in the serum C-terminal telopeptide of type I collagen (Serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum cortisol and fasting","volume":"31","author":"Qvist","year":"2002","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2003.18.10.1789","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/10\/1789\/56468620\/5650181010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/18\/10\/1789\/56468620\/5650181010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:05:52Z","timestamp":1710342352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/18\/10\/1789-1794\/7592185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2003.18.10.1789","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2003,10,1]]},"published":{"date-parts":[[2003,10,1]]}}}